AS
ADAM STEINMETZ
BROWNSTEIN HYATT FARBER SCHRECK, LLP · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
29
last 3 years
Filings
79
10 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Policy Advisor - Committee on the Budget
United States House of Representatives
Disclosed on LD-2 filings
Career
BH
Specific issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Engagement regarding VAs Integrated Critical Staffing Program Award.
Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain
Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues S. 476/H.R.5547 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues
Clients
Filing history
ELI LILLY AND COMPANY
NOVARTIS
ALLEGIS, REDWOOD, MAXIM PUBLIC AFFAIRS, LLC
CENCORA, INC.
NORTHERN COMPASS GROUP LLC OBO PETERSBURG MEDICAL CENTER
PARTICLE HEALTH
HARMONY BIOSCIENCES
MARIDOSE LLC
LIFEPOINT HEALTH
PERNOD RICARD USA
NOVARTIS
ABBVIE